All In MedTech

Device Trial Radar · NCT05657392

Quantitative EEG Changes Following Repetitive Transcranial Magnetic Stimulation in Patients With Post Stroke (EEG-rTMS)

Examination of Changes in Quantitative EEG Parameters Based on Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment in Patients With Post Stroke

Last checked: Nov 19, 2026Latest source record: Dec 20, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

50

Planned (sponsor's estimate)

Start

Apr 15, 2021

Primary completion

Oct 15, 2023

Study completion Apr 15, 2024

Sponsor

Lead sponsor
Izmir Katip Celebi UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
The Scientific and Technological Research Council of Turkey
First posted
Dec 20, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Quantitative EEG (qEEG) has been used as an effective tool in the diagnosis and prognosis of brain-related diseases. In the literature, a variety of qEEG parameters have been proven informative in the prognosis of stroke. In addition, it has been demonstrated that changes in certain qEEG parameters during traditional/task-specific rehabilitation approaches are correlated with clinical outcomes of functional motor recovery. Repetitive transcranial magnetic stimulation (rTMS) has been proposed as a non-invasive and therapeutic treatment used to accelerate and enhance the recovery process of motor function in stroke patients. Many studies have reported that inhibiting contralesional rTMS may have positive effects in stroke patients with severe upper extremity motor impairment. In this context, the aim of the proposed study is to investigate whether there is a correlation between the change in qEEG parameters and the improvement of motor functions associated with rTMS treatment and to provide an electrophysiological prognostic biomarker of inhibiting contralesional rTMS for stroke patients.

Conditions

  • Stroke
  • Stroke, Ischemic
  • Stroke/Brain Attack

Interventions

  • repetitive Transcranial Magnetic Stimulation (rTMS)Device

    Repetitive Transcranial Magnetic Stimulation (rTMS) is a noninvasive intervention that uses magnetic fields to stimulate nerve cells to improve the symptoms of a variety of disorders, including stroke-related motor impairment. Last few decades, it has been revealed that rTMS accelerates motor recovery and may reduce stroke-related symptoms.

  • 32 electrode electroencephalography (EEG)Other

    32-electrode EEG will be non-invasively recorded from electrodes placed in a montage over the scalp while the participant is resting

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in The Fugl-Meyer Assessment (FMA)Time frame: (1) Baseline, (2) At the end of the last session of the intervention (immediately after the 10th session, each session is 1 day)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Izmir Katip Celebi University

    Izmir, Cigli, Turkey (Türkiye) · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.